Malta - English - Malta Medicines Authority

msn labs europe limited kw20a, corradino park, paola pla 3000, malta - gastro-resistant hard capsule - dimethyl fumarate 240 mg - immunosuppressants

European Union - English - EMA (European Medicines Agency)

biogen netherlands b.v. - dimethyl fumarate - multiple sclerosis - immunosuppressants - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Canada - English - Health Canada

biogen canada inc - dimethyl fumarate - capsule (delayed release) - 120mg - dimethyl fumarate 120mg - immunomodulatory agents

Canada - English - Health Canada

biogen canada inc - dimethyl fumarate - capsule (delayed release) - 240mg - dimethyl fumarate 240mg - immunomodulatory agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (germany) - magnesium monoethyl fumarate; zinc monoethyl fumarate; dimethyl fumarate; calcium monoethyl fumarate - gastro-resistant tablet - 5mg ; 3mg ; 120mg ; 87mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (germany) - calcium monoethyl fumarate; magnesium monoethyl fumarate; zinc monoethyl fumarate; dimethyl fumarate - gastro-resistant tablet - 67mg ; 5mg ; 3mg ; 30mg

Israel - English - Ministry of Health

teva israel ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimethyl fumarate - dimethyl fumarate teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis

Israel - English - Ministry of Health

teva israel ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimethyl fumarate - dimethyl fumarate teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis

European Union - English - EMA (European Medicines Agency)

mylan ireland limited - lenalidomide - multiple myeloma - immunosuppressants - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation.lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant.lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

European Union - English - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - multiple sclerosis, relapsing-remitting - immunosuppressants - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5.1 for important information on the populations for which efficacy has been established).